Oncology Research Hub

Explore cutting-edge studies in tumor biology, molecular pathways, and clinical breakthroughs

Research Articles

Jamming Cancer's Communication Lines: How a Revolutionary Antibody Disrupts Myeloma's Survival Network

Discover how SAR650984 (isatuximab) disrupts the CD38-CD31 adhesion axis in multiple myeloma, unmoors cancer cells from bone marrow, and triggers multiple lethal pathways.

Camila Jenkins
Aug 10, 2025

Popular Articles